Comparison of Indocyanine Green with conventional tracers for sentinel lymph node biopsy in breast cancer: A multidisciplinary evaluation of clinical effectiveness, safety, organizational and economic impact
This study provided strong evidence for ICG's clinical and economic value for SLNB in breast cancer. It ascertained ICG as a valuable alternative to conventional tracers, ensuring clinical effectiveness along with economic and organizational benefits.
Authors
- Laura Marone
- Claudio Botti (ORCID: https://orcid.org/0000-0002-5814-6876)
- Emanuele Lettieri (ORCID: https://orcid.org/0000-0003-1235-989X)
- Francesca Pellini (ORCID: https://orcid.org/0000-0002-2286-9060)
- Chiara Gerardi (ORCID: https://orcid.org/0000-0002-2459-4769)
- Lorenzo Bertoldi
- Massimo Costantini (ORCID: https://orcid.org/0000-0002-5293-7079)
- Maria Pinelli (ORCID: https://orcid.org/0000-0002-3993-0585)
- Giuseppe Navanteri
- Madalina Maioru
Institutions
- Mario Negri Institute for Pharmacological Research (IT)
- Azienda Ospedaliera Universitaria Integrata Verona (IT)
- Tumori Foundation (US)
- Istituti di Ricovero e Cura a Carattere Scientifico (IT)
- Fondazione IRCCS Istituto Nazionale dei Tumori (IT)
- Instituto Nazionale Tumori Regina Elena (IT)
- Politecnico di Milano (IT)
Publication Details
- Journal
- PLoS ONE
- Published
- 2024-08-29
- DOI
- https://doi.org/10.1371/journal.pone.0309336
- Citations
- 17
- Primary Topic
- Breast Cancer Treatment Studies
- Type
- article
- Field-Weighted Citation Impact
- 4.85